Showing results (271-280 of 383) with videos related to
Sort By:
Pageof 39
Current Medical Research and Opinion|September 13, 2008
Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrelDavid S Small, Nagy A Farid, Ying G Li, et al.European Heart Journal|December 7, 2007
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery diseaseLars Wallentin, Christoph Varenhorst, Stefan James, et al.Molecular Cell|March 17, 2018
CDK and MAPK Synergistically Regulate Signaling Dynamics via a Shared Multi-site Phosphorylation Region on the Scaffold Protein Ste5María Victoria Repetto, Matthew J Winters, Alan Bush, et al.Journal of Substance Abuse Treatment|May 1, 2018
A randomized clinical trial of motivational enhancement therapy for alcohol problems in partner violent menChristopher M Murphy, Laura A Ting, Lisa C Jordan, et al.Clinical Pharmacokinetics|November 9, 2010
Effect of intrinsic and extrinsic factors on the clinical pharmacokinetics and pharmacodynamics of prasugrelDavid S Small, Nagy A Farid, Christopher D Payne, et al.Journal of Clinical Pharmacy and Therapeutics|September 12, 2009
Pharmacokinetics and pharmacodynamics of prasugrel in subjects with moderate liver diseaseD S Small, N A Farid, Y G Li, et al.Journal of Clinical Pharmacology|December 21, 2007
Prasugrel, a new thienopyridine antiplatelet drug, weakly inhibits cytochrome P450 2B6 in humansNagy A Farid, Christopher D Payne, C Steven Ernest, et al.The Journal of Clinical Endocrinology and Metabolism|August 1, 1997
Circulating concentrations of dimeric inhibin A and B in the male rhesus monkey (Macaca mulatta)T M Plant, V Padmanabhan, S Ramaswamy, et al.European Heart Journal|April 20, 2006
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery diseaseTomas Jernberg, Christopher D Payne, Kenneth J Winters, et al.Platelets|August 21, 2014
The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell diseaseJoseph A Jakubowski, Chunmei Zhou, Kenneth J Winters, et al.Pageof 39